These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1063 related items for PubMed ID: 20649798
21. Etanercept treatment for children and adolescents with plaque psoriasis. Paller AS, Siegfried EC, Langley RG, Gottlieb AB, Pariser D, Landells I, Hebert AA, Eichenfield LF, Patel V, Creamer K, Jahreis A, Etanercept Pediatric Psoriasis Study Group. N Engl J Med; 2008 Jan 17; 358(3):241-51. PubMed ID: 18199863 [Abstract] [Full Text] [Related]
26. Treatment of erythrodermic psoriasis with etanercept. Esposito M, Mazzotta A, de Felice C, Papoutsaki M, Chimenti S. Br J Dermatol; 2006 Jul 17; 155(1):156-9. PubMed ID: 16792768 [Abstract] [Full Text] [Related]
29. Predicting treatment response in psoriasis using serum levels of adalimumab and etanercept: a single-centre, cohort study. Mahil SK, Arkir Z, Richards G, Lewis CM, Barker JN, Smith CH. Br J Dermatol; 2013 Aug 17; 169(2):306-13. PubMed ID: 23550925 [Abstract] [Full Text] [Related]
31. Adalimumab therapy for psoriasis in real-world practice: efficacy, safety and results in biologic-naïve vs. non-naïve patients. van Lümig PP, van de Kerkhof PC, Boezeman JB, Driessen RJ, de Jong EM. J Eur Acad Dermatol Venereol; 2013 May 17; 27(5):593-600. PubMed ID: 22416818 [Abstract] [Full Text] [Related]
35. Efficacy and safety of adalimumab in psoriatic patients previously treated with etanercept in a real-world setting. Fonseca E, Iglesias R, Paradela S, Fernández-Torres RM, Elberdín L. J Dermatolog Treat; 2015 Jun 17; 26(3):217-22. PubMed ID: 24920071 [Abstract] [Full Text] [Related]
36. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial. Kircik LH. J Drugs Dermatol; 2011 Aug 17; 10(8):878-82. PubMed ID: 21818509 [Abstract] [Full Text] [Related]
37. Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study. Esposito M, Gisondi P, Cassano N, Ferrucci G, Del Giglio M, Loconsole F, Giunta A, Vena GA, Chimenti S, Girolomoni G. Br J Dermatol; 2013 Sep 17; 169(3):666-72. PubMed ID: 23647206 [Abstract] [Full Text] [Related]
39. Treatment effect of adalimumab and infliximab in Japanese psoriasis patients: results in a single community-based hospital. Noda S, Mizuno K, Adachi M. J Dermatol; 2012 Mar 17; 39(3):265-8. PubMed ID: 22126280 [Abstract] [Full Text] [Related]
40. Practical understanding of mean percent psoriasis area and severity index reduction for biologics. English PL, Vender R. J Cutan Med Surg; 2008 Mar 17; 12(6):282-7. PubMed ID: 19317950 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]